Addiction Disorders Drugs Market by Drug Type (Alcohol, Marijuana, Prescription & Over-the-Counter Medications), Treatment (Counseling & Behavioral Therapies, Detoxification, Medications), End-user - Global Forecast 2024-2030

Addiction Disorders Drugs Market by Drug Type (Alcohol, Marijuana, Prescription & Over-the-Counter Medications), Treatment (Counseling & Behavioral Therapies, Detoxification, Medications), End-user - Global Forecast 2024-2030


The Addiction Disorders Drugs Market size was estimated at USD 25.46 billion in 2023 and expected to reach USD 27.08 billion in 2024, at a CAGR 6.46% to reach USD 39.47 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Addiction Disorders Drugs Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Addiction Disorders Drugs Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Addiction Disorders Drugs Market, highlighting leading vendors and their innovative profiles. These include Accord Healthcare Limited, Alkermes PLC, Aurobindo Pharma Limited, BioCorRx Inc., Cipla Limited, Consern Pharma Limited, GlaxoSmithKline PLC, Insys Therapeutics, Mallinckrodt Pharmaceuticals, Medtronic PLC, Novartis AG, Perrigo Company PLC, Pfizer, Inc, Psychemedics Corporation, Purdue Pharma L.P., Reckitt Benckiser Pharmaceuticals, Inc., Sun Pharmaceutical Industries Limited, Takeda Pharmaceutical Company Ltd, and Teva Pharmaceutical Industries, Ltd.

Market Segmentation & Coverage

This research report categorizes the Addiction Disorders Drugs Market to forecast the revenues and analyze trends in each of the following sub-markets:

Drug Type

Alcohol
  • Marijuana
  • Prescription & Over-the-Counter Medications
  • Synthetic Cannabinoids
  • Tobacco/Nicotine & Vaping
  • Treatment

    Counseling & Behavioral Therapies
  • Detoxification
  • Medications
  • Rehabilitation Programs
  • Self-Help Groups
  • End-user

    Hospital & Clinics
  • Residential Treatment Centers
  • Region

    Americas

    Argentina
  • Brazil
  • Canada
  • Mexico
  • United States

    California
  • Florida
  • Illinois
  • New York
  • Ohio
  • Pennsylvania
  • Texas
  • Asia-Pacific

    Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
  • Vietnam
  • Europe, Middle East & Africa

    Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom
    The report offers valuable insights on the following aspects:

    1. Market Penetration: It presents comprehensive information on the market provided by key players.
    2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
    3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
    4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
    5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
    The report addresses key questions such as:

    1. What is the market size and forecast of the Addiction Disorders Drugs Market?
    2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Addiction Disorders Drugs Market?
    3. What are the technology trends and regulatory frameworks in the Addiction Disorders Drugs Market?
    4. What is the market share of the leading vendors in the Addiction Disorders Drugs Market?
    5. Which modes and strategic moves are suitable for entering the Addiction Disorders Drugs Market?


    Note: PDF & Excel + Online Access - 1 Year

  • 1. Preface
    1.1. Objectives of the Study
    1.2. Market Segmentation & Coverage
    1.3. Years Considered for the Study
    1.4. Currency & Pricing
    1.5. Language
    1.6. Limitations
    1.7. Assumptions
    1.8. Stakeholders
    2. Research Methodology
    2.1. Define: Research Objective
    2.2. Determine: Research Design
    2.3. Prepare: Research Instrument
    2.4. Collect: Data Source
    2.5. Analyze: Data Interpretation
    2.6. Formulate: Data Verification
    2.7. Publish: Research Report
    2.8. Repeat: Report Update
    3. Executive Summary
    4. Market Overview
    4.1. Introduction
    4.2. Addiction Disorders Drugs Market, by Region
    5. Market Insights
    5.1. Market Dynamics
    5.1.1. Drivers
    5.1.1.1. Increasing prevalences of addictive substances such as alcohol, tobacco, and drugs among all age groups
    5.1.1.2. Government intervention and encouragement to curb addiction disorders
    5.1.1.3. Rising number of approved medicines and the increased use of nicotine with other stimulants
    5.1.2. Restraints
    5.1.2.1. Limited awareness about addiction treatment products in developing countries
    5.1.2.2. Multiple side-effects associated with the use of methadone
    5.1.3. Opportunities
    5.1.3.1. Availability of innovative drugs in the form of pills, sublingual films, and implants
    5.1.4. Challenges
    5.1.4.1. Legal obligations for addiction treatment products
    5.2. Market Segmentation Analysis
    5.3. Market Trend Analysis
    5.4. Cumulative Impact of High Inflation
    5.5. Porter’s Five Forces Analysis
    5.5.1. Threat of New Entrants
    5.5.2. Threat of Substitutes
    5.5.3. Bargaining Power of Customers
    5.5.4. Bargaining Power of Suppliers
    5.5.5. Industry Rivalry
    5.6. Value Chain & Critical Path Analysis
    5.7. Regulatory Framework
    6. Addiction Disorders Drugs Market, by Drug Type
    6.1. Introduction
    6.2. Alcohol
    6.3. Marijuana
    6.4. Prescription & Over-the-Counter Medications
    6.5. Synthetic Cannabinoids
    6.6. Tobacco/Nicotine & Vaping
    7. Addiction Disorders Drugs Market, by Treatment
    7.1. Introduction
    7.2. Counseling & Behavioral Therapies
    7.3. Detoxification
    7.4. Medications
    7.5. Rehabilitation Programs
    7.6. Self-Help Groups
    8. Addiction Disorders Drugs Market, by End-user
    8.1. Introduction
    8.2. Hospital & Clinics
    8.3. Residential Treatment Centers
    9. Americas Addiction Disorders Drugs Market
    9.1. Introduction
    9.2. Argentina
    9.3. Brazil
    9.4. Canada
    9.5. Mexico
    9.6. United States
    10. Asia-Pacific Addiction Disorders Drugs Market
    10.1. Introduction
    10.2. Australia
    10.3. China
    10.4. India
    10.5. Indonesia
    10.6. Japan
    10.7. Malaysia
    10.8. Philippines
    10.9. Singapore
    10.10. South Korea
    10.11. Taiwan
    10.12. Thailand
    10.13. Vietnam
    11. Europe, Middle East & Africa Addiction Disorders Drugs Market
    11.1. Introduction
    11.2. Denmark
    11.3. Egypt
    11.4. Finland
    11.5. France
    11.6. Germany
    11.7. Israel
    11.8. Italy
    11.9. Netherlands
    11.10. Nigeria
    11.11. Norway
    11.12. Poland
    11.13. Qatar
    11.14. Russia
    11.15. Saudi Arabia
    11.16. South Africa
    11.17. Spain
    11.18. Sweden
    11.19. Switzerland
    11.20. Turkey
    11.21. United Arab Emirates
    11.22. United Kingdom
    12. Competitive Landscape
    12.1. FPNV Positioning Matrix
    12.2. Market Share Analysis, By Key Player
    12.3. Competitive Scenario Analysis, By Key Player
    13. Competitive Portfolio
    13.1. Key Company Profiles
    13.1.1. Accord Healthcare Limited
    13.1.2. Alkermes PLC
    13.1.3. Aurobindo Pharma Limited
    13.1.4. BioCorRx Inc.
    13.1.5. Cipla Limited
    13.1.6. Consern Pharma Limited
    13.1.7. GlaxoSmithKline PLC
    13.1.8. Insys Therapeutics
    13.1.9. Mallinckrodt Pharmaceuticals
    13.1.10. Medtronic PLC
    13.1.11. Novartis AG
    13.1.12. Perrigo Company PLC
    13.1.13. Pfizer, Inc
    13.1.14. Psychemedics Corporation
    13.1.15. Purdue Pharma L.P.
    13.1.16. Reckitt Benckiser Pharmaceuticals, Inc.
    13.1.17. Sun Pharmaceutical Industries Limited
    13.1.18. Takeda Pharmaceutical Company Ltd
    13.1.19. Teva Pharmaceutical Industries, Ltd
    13.2. Key Product Portfolio
    14. Appendix
    14.1. Discussion Guide
    14.2. License & Pricing
    FIGURE 1. ADDICTION DISORDERS DRUGS MARKET RESEARCH PROCESS
    FIGURE 2. ADDICTION DISORDERS DRUGS MARKET SIZE, 2023 VS 2030
    FIGURE 3. ADDICTION DISORDERS DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
    FIGURE 4. ADDICTION DISORDERS DRUGS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
    FIGURE 5. ADDICTION DISORDERS DRUGS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 6. ADDICTION DISORDERS DRUGS MARKET DYNAMICS
    FIGURE 7. ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG TYPE, 2023 VS 2030 (%)
    FIGURE 8. ADDICTION DISORDERS DRUGS MARKET SIZE, BY DRUG TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 9. ADDICTION DISORDERS DRUGS MARKET SIZE, BY TREATMENT, 2023 VS 2030 (%)
    FIGURE 10. ADDICTION DISORDERS DRUGS MARKET SIZE, BY TREATMENT, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 11. ADDICTION DISORDERS DRUGS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
    FIGURE 12. ADDICTION DISORDERS DRUGS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 13. AMERICAS ADDICTION DISORDERS DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
    FIGURE 14. AMERICAS ADDICTION DISORDERS DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 15. UNITED STATES ADDICTION DISORDERS DRUGS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
    FIGURE 16. UNITED STATES ADDICTION DISORDERS DRUGS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 17. ASIA-PACIFIC ADDICTION DISORDERS DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
    FIGURE 18. ASIA-PACIFIC ADDICTION DISORDERS DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ADDICTION DISORDERS DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
    FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ADDICTION DISORDERS DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
    FIGURE 21. ADDICTION DISORDERS DRUGS MARKET, FPNV POSITIONING MATRIX, 2023
    FIGURE 22. ADDICTION DISORDERS DRUGS MARKET SHARE, BY KEY PLAYER, 2023

    Download our eBook: How to Succeed Using Market Research

    Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

    Download eBook
    Cookie Settings